USPH’s Persistent Underperformance and Growing Risk Flags Signal a Fragile Rally

Four risk alerts and a bull‑high‑vol regime raise questions about the next 6‑12 months

USPH U.S. Physical Therapy, Inc.

In this report

01

Returns Overview

Period returns, alpha, cumulative performance, distributions

P. 2-3

→

02

Volatility Analysis

Annualized volatility, downside deviation, drawdowns

P. 4-5

→

03

Beta & Correlation

Trailing, upside, downside beta, systematic risk

P. 6-7

→

04

Risk-Adjusted Returns

Sharpe, Sortino, Calmar, Information, Treynor

P. 8-9

→

05

Market Regime Analysis

Bull/bear behavior, capture ratios

P. 10-11

→

06

Investment Highlights & Risk Summary

Executive summary, risk flags, rankings

P. 12-13

→

Returns Overview

U.S. Physical Therapy, Inc. (USPH) — Return Performance

U.S. Physical Therapy, Inc. (USPH) has underperformed its healthcare sector benchmark across all measured horizons, delivering negative absolute returns while the sector posted positive gains over short periods and modest growth over longer terms. Over the past month USPH fell 1.26% versus a sector alpha of +1.33%, widening to a 15‑month cumulative loss of 45.33% against an even steeper sector outperformance of -111.24%, indicating persistent relative weakness.

Period Returns vs S&P 500 & XLV

Monthly Returns Heatmap

USPH

The stock generated negative alpha in every interval, with the most pronounced divergence occurring over the three‑year horizon where USPH lost 45.33% while the sector posted a +111.24% outperformance. Short‑term performance (1M) showed only a modest lag of -2.59 percentage points versus sector alpha, but the gap widens dramatically in longer windows, highlighting sustained underperformance and limited upside potential relative to its peers.

Returns Overview

U.S. Physical Therapy, Inc. (USPH) — Return Charts

Volatility Analysis

U.S. Physical Therapy, Inc. (USPH) — Volatility Profile

U.S. Physical Therapy, Inc. (USPH) exhibits markedly higher volatility than the broader market, with an annualized volatility of 38.56% versus the S&P 500's 17.78%, indicating more than double the price fluctuation on a yearly basis. The stock’s downside risk is pronounced: a downside deviation of 32.19% and a maximum historical drawdown of -67.21% from its November 2019 peak to March 2020, with no subsequent recovery, underscore significant vulnerability during market stress periods. Recent short‑term volatility remains elevated; the 60‑day vol of 51.64% and 252‑day vol of 40.98% both exceed the long‑term average of 38.56%, suggesting that price swings have intensified in the current environment.

Volatility Metrics

USPH

The stock’s volatility profile is substantially above benchmark levels, reflecting heightened sensitivity to sector-specific and macroeconomic shocks. Downside metrics reveal a steep risk tilt: the downside deviation of 32.19% translates to larger losses than upside gains on average, while the -67.21% max drawdown demonstrates deep, prolonged loss potential that has not yet been reclaimed. Moreover, the current trailing volatilities—51.64% over 60 days and 40.98% over 252 days—are both higher than the long‑term annualized figure, indicating that recent price movements are more erratic than historically typical.

USPH's annualized volatility is more than twice that of the S&P 500 (38.56% vs 17.78%).
Downside deviation stands at 32.19%, highlighting a pronounced bias toward larger losses.
Maximum drawdown of -67.21% occurred during the COVID‑19 sell‑off and remains unrecovered.
Both 60‑day (51.64%) and 252‑day (40.98%) volatilities exceed the long‑term average, signaling heightened recent risk.
The stock lacks any sign of recovery from its deepest drawdown, emphasizing persistent downside pressure.

Positive Characteristics
Despite high volatility, the elevated price swings can create entry opportunities for contrarian investors seeking mean reversion.
The absence of a full recovery from the max drawdown leaves upside potential if earnings growth or sector dynamics improve.

Volatility Analysis

U.S. Physical Therapy, Inc. (USPH) — Volatility & Drawdown Charts

Beta & Correlation

U.S. Physical Therapy, Inc. (USPH) — Beta Profile

U.S. Physical Therapy, Inc. (USPH) exhibits a trailing beta of 1.036 versus the S&P 500, positioning it squarely within the market‑like range of 0.8–1.2. This indicates that, on average, the stock moves in line with broader equity markets, neither providing strong defensive shelter nor amplifying market swings. The upside beta of 1.043 versus a downside beta of 1.155 reveals modest asymmetry: the share tends to fall slightly more sharply than it rises during market stress, a nuance that risk‑aware investors should monitor. The stock’s R-squared of 22.8% signals that less than one quarter of its price variance is explained by movements in the S&P 500, leaving 77.2% as idiosyncratic or company‑specific risk. When benchmarked against the Healthcare sector (XLV), USPH’s sector beta of 0.937 and sector correlation of 0.407 suggest that roughly 16.6% of its returns are driven by sector dynamics, while the remaining variance stems from broader market exposure and firm‑level factors. Decomposing risk shows a higher proportion of idiosyncratic volatility than systematic, underscoring the importance of diversification for investors holding this stock.

Beta & Correlation Metrics

USPH

The trailing beta of 1.036 places USPH in the market‑like band, meaning its price reacts proportionally to overall equity movements without extreme amplification. However, the downside beta of 1.155 exceeds the upside figure (1.043), indicating a slight tilt toward greater loss sensitivity during market declines—a characteristic that can heighten portfolio drawdowns in bearish environments. USPH’s low R-squared (22.8%) and modest sector correlation (0.407) highlight that most price movements are driven by firm‑specific events rather than sector or market trends. Consequently, while the stock tracks the market on average, its performance can diverge substantially from both the S&P 500 and the Healthcare sector, offering potential for active managers to capture alpha but also demanding careful risk monitoring.

Trailing beta of 1.036 classifies USPH as market‑like, not defensive or aggressive.
Downside beta (1.155) exceeds upside beta (1.043), indicating slightly higher loss sensitivity in downturns.
R-squared of 22.8% shows that 77.2% of price variance is idiosyncratic, limiting diversification benefits from market exposure alone.
Sector beta of 0.937 and sector R² of 16.6% reveal limited reliance on Healthcare sector movements for return generation.
Systematic risk (22.8%) is modest compared with idiosyncratic risk (77.2%), emphasizing the importance of company‑specific factors.

Positive Characteristics
Market‑like beta provides exposure to equity upside without excessive volatility.
Low sector correlation suggests USPH can add diversification within a healthcare‑heavy portfolio.
High idiosyncratic component offers opportunities for active managers to generate alpha through firm‑level insights.

Beta & Correlation

U.S. Physical Therapy, Inc. (USPH) — Rolling Beta

Positive Notes

Market‑like beta provides exposure to equity upside without excessive volatility.

Low sector correlation suggests USPH can add diversification within a healthcare‑heavy portfolio.

High idiosyncratic component offers opportunities for active managers to generate alpha through firm‑level insights.

Risk-Adjusted Returns

U.S. Physical Therapy, Inc. (USPH) — Risk-Adjusted Performance

U.S. Physical Therapy, Inc. (USPH) delivers modest risk-adjusted returns relative to conventional benchmarks. A Sharpe ratio of 0.238 falls well below the 1.0 threshold that signals a favorable return per unit of total volatility, indicating that the stock’s excess return over the 3.63% risk‑free rate is limited after accounting for overall risk. Nonetheless, the Sortino ratio of 0.285 exceeds the Sharpe figure, suggesting that downside volatility is less pronounced than total volatility and that the equity may preserve capital better during market declines.

Risk-free rate: 3.63% (Fed Funds Rate)

Risk-Adjusted Metrics

USPH

The Calmar ratio of 0.191 reflects a relatively weak performance when measured against the company’s maximum historical drawdown; each percentage point of return is offset by roughly five points of peak‑to‑trough loss, highlighting susceptibility to sizable declines. The Information Ratio of 0.001 is effectively zero, implying that any active management or alpha generation has been negligible and not statistically consistent. However, the Treynor ratio of 8.867 indicates a high return per unit of systematic (beta) risk, meaning USPH’s market‑related returns are strong relative to its exposure to broader equity movements.

Sharpe ratio (0.238) is well below the 1.0 benchmark, signaling limited excess return for total volatility.
Sortino ratio (0.285) exceeds Sharpe, indicating a more favorable downside risk profile than overall risk.
Calmar ratio (0.191) points to significant drawdown severity relative to returns.
Information Ratio near zero shows negligible consistent alpha generation.
Treynor ratio (8.867) suggests robust return per unit of systematic market risk.

Positive Characteristics
Sortino ratio above Sharpe reflects a comparatively gentle downside volatility environment.
High Treynor ratio demonstrates strong compensation for exposure to market risk.

Risk-Adjusted Returns

U.S. Physical Therapy, Inc. (USPH) — Rolling Sharpe & Sortino

Positive Notes

Sortino ratio above Sharpe reflects a comparatively gentle downside volatility environment.

High Treynor ratio demonstrates strong compensation for exposure to market risk.

Market Regime Analysis

U.S. Physical Therapy, Inc. (USPH) — Regime Behavior

U.S. Physical Therapy, Inc. (USPH) demonstrates markedly divergent performance across market regimes, delivering strong upside in bullish environments while exhibiting heightened vulnerability during bearish periods. In Bull-LowVol conditions the stock posts an average monthly return of 1.94%, reflecting its ability to capitalize on steady market advances; however, this advantage erodes in Bull-HighVol settings where returns fall to 0.98% despite the broader market’s upward trajectory. Conversely, USPH suffers pronounced losses when markets turn bearish, with a -5.32% average monthly decline in Bear-LowVol regimes and only a modest -0.44% loss during Bear-HighVol periods, indicating that heightened volatility in downturns somewhat cushions its downside but does not eliminate it. The current Bull-HighVol regime—characterized by an up‑trending S&P 500 coupled with elevated realized volatility—places USPH in a context where its upside capture is muted relative to calmer bullish phases.

Current Market Regime: Bull-HighVol

Bull-LowVol = calm uptrend • Bull-HighVol = volatile uptrend • Bear-LowVol = orderly decline • Bear-HighVol = crisis

Regime Returns & Capture Ratios

USPH

During Bull-LowVol periods, USPH’s upside capture of 119.7% translates into returns that exceed the S&P 500 by roughly 20%, underscoring its growth orientation in stable up‑markets. In Bull-HighVol regimes, the same upside capture is tempered, yielding a modest 0.98% average monthly return, suggesting sensitivity to market turbulence despite still outperforming the broader index on a relative basis. The stock’s downside capture of 143.9% reveals pronounced weakness in bear markets, as evidenced by a -5.32% average loss in Bear-LowVol conditions; however, the less severe -0.44% decline in Bear-HighVol periods indicates that extreme volatility can partially offset its defensive shortcomings. Overall, USPH’s capture ratio of 0.83 (upside/downside) falls below the ideal benchmark of >1.0, signaling that the firm captures more downside than upside on a risk‑adjusted basis.

Market Regime Analysis

U.S. Physical Therapy, Inc. (USPH) — Regime & Capture Charts

Regime Timeline

USPH excels in calm bullish markets with an upside capture of 119.7% and a 1.94% average monthly return.
In volatile bull markets, returns drop to 0.98%, highlighting sensitivity to heightened market volatility.
Downside capture of 143.9% leads to steep losses in Bear-LowVol regimes (-5.32%) but is mitigated during Bear-HighVol periods (-0.44%).
The overall capture ratio of 0.83 indicates the stock captures more downside than upside, falling short of the >1.0 ideal.
Current Bull-HighVol regime suggests muted upside potential for USPH relative to its performance in calmer up‑trends.

Positive Characteristics
Strong upside capture (119.7%) during stable bullish phases demonstrates growth capability.
Reduced loss magnitude in Bear-HighVol (-0.44% vs -5.32% in Bear-LowVol) shows some resilience under extreme volatility.

Investment Highlights & Risk Summary

U.S. Physical Therapy, Inc. (USPH) — Summary & Implications

U.S. Physical Therapy, Inc. (USPH) has delivered a 1‑year total return of -18.42%, trailing both the S&P 500 and its healthcare sector benchmark XLV by wide margins. The stock’s alpha of -37.42% versus the market and sector alpha of -32.95% reflect persistent underperformance, while an annualized volatility of 38.56% signals a highly volatile price profile. Risk metrics further underscore downside bias: a beta of 1.036 combined with a downside capture ratio of 143.9% indicates that USPH magnifies market declines, and the Sharpe (0.238) and Sortino (0.285) ratios are well below conventional thresholds for attractive risk‑adjusted returns. Nonetheless, the company’s upside capture of 119.7% shows it participates in market rallies, albeit insufficient to offset its heavy loss exposure. Investors should weigh the deep historical drawdown of -67.21% and the asymmetric risk profile against any potential upside from sector recovery or operational improvements.

Summary Dashboard

Investment Highlights

Upside capture of 119.7% demonstrates that USPH participates in market gains, outperforming the S&P 500 on the up‑side.
Beta of 1.036 suggests exposure roughly aligned with overall market movements, providing a familiar risk level for equity investors.
The company’s revenue model is anchored in fee‑for‑service physical therapy, which historically offers recession‑resilient cash flows.

Risk-Return Rankings

USPH HIGH

High volatility and pronounced downside capture produce a risk‑heavy profile with modest upside participation.

Strength: Upside capture above 100% (119.7%) indicates potential for rally participation.

Concern: Deep drawdown of -67.21% and downside capture of 143.9% signal severe loss risk.

Key Takeaways

USPH’s Sharpe (0.238) and Sortino (0.285) ratios are far below the typical benchmark of 1.0, indicating weak risk‑adjusted performance.
The stock’s downside capture exceeds its upside capture, creating an unfavorable asymmetry that amplifies market declines.
Annualized volatility of 38.56% is more than double the S&P 500’s 17.1%, reflecting heightened price swings.
Sector underperformance of -32.95% over the past year suggests the company lags behind broader healthcare trends.

PORTFOLIO IMPLICATIONS

Given its high volatility and pronounced downside bias, USPH is best suited for a small, speculative allocation within a diversified equity portfolio rather than as a core holding. Its upside capture can provide incremental participation in market rallies, but investors should balance this with assets that exhibit lower beta and stronger risk‑adjusted returns to mitigate the potential impact of deep drawdowns. Pairing USPH with defensive healthcare stocks or low‑beta large‑cap equities could help smooth overall portfolio volatility while preserving some exposure to sector recovery.

USPH

Related Reports

Visit finexus.net/reports for more reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.